Measles Clinical Trials

109 clinical trials for Measles across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age — RECRUITING · PHASE3
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective — RECRUITING
• Measles and BCG Vaccines for Mother and Child — RECRUITING · PHASE4
• Register study on neuroprognostics in patients with neurological / neurosurgical diseases in intensive care unit — RECRUITING
• Immunity against vaccine-preventable diseases in the homeless population in Germany — RECRUITING
• A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age — NOT_YET_RECRUITING · PHASE3
• A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01). — NOT_YET_RECRUITING · PHASE4
• Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR — COMPLETED · PHASE4
• the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines — NOT_YET_RECRUITING
• Video Intervention for Early Childhood Vaccination Education — NOT_YET_RECRUITING
• Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) — COMPLETED · PHASE4
• Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections — NOT_YET_RECRUITING
• Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age — COMPLETED · PHASE4
• A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age — COMPLETED · PHASE2
• Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal — NOT_YET_RECRUITING
• Barriers and Facilitators to MMR Vaccination Among Healthcare Workers — COMPLETED
• A Tool Kit to Improve Vaccine Confidence in the Philippines — ACTIVE_NOT_RECRUITING · NA
• Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months — NOT_YET_RECRUITING · PHASE3
• Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience — COMPLETED
• Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings — OTHER · PHASE2
• Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination — OTHER · PHASE3
• Co-administration Study of OCV, TCV and MR — OTHER · PHASE3
• Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines — OTHER · PHASE4
• Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed — COMPLETED
• Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial — OTHER · NA
• Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial — COMPLETED · PHASE1
• Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya — COMPLETED · NA
• Ontogeny of Measles Immunity in Infants — COMPLETED
• The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine — OTHER · PHASE4
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs — COMPLETED · NA
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group — COMPLETED · PHASE2
• Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011) — COMPLETED · PHASE3
• Measles, Mumps, and Rubella (MMR) Immunity in College Students — COMPLETED
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — COMPLETED · PHASE3
• Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine — COMPLETED · PHASE4
• Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients — OTHER · PHASE4
• Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella — COMPLETED · PHASE2
• Evaluation of an Infant Immunization Encouragement Program in Nigeria — COMPLETED · NA
• Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine — OTHER · PHASE4
• Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age — COMPLETED · PHASE2
• Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) — COMPLETED · PHASE2
• Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda — COMPLETED · NA
• Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age — COMPLETED · PHASE3
• Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) — COMPLETED · PHASE3
• Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds — COMPLETED · PHASE2
• Measles Vaccination Cash Incentives Experimental Evidence From Nigeria — COMPLETED · NA
• Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) — COMPLETED · PHASE4
• Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) — COMPLETED · PHASE3
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age — COMPLETED · PHASE2
• Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children — COMPLETED · PHASE3

Refine this search